ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹62 Cr | ₹229 Cr | ₹227 Cr | ₹-16 Cr | ₹-197 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹62 Cr |
| Mar2025 | ₹229 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-197 Cr |
How is Deferred Tax Assets / Liabilities of ERIS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹62 Cr | -72.90 | |
| Mar2025 | ₹229 Cr | 0.87 | |
| Mar2024 | ₹227 Cr | Positive | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-197 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹16,330.5 Cr | 0.1% | -1.1% | -28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 0.1% |
-1.1% |
-28.4% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses